SEC Form 4 · accession 0001104659-18-058111
Kiniksa Pharmaceuticals International, plc · KNSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanj K Patel
Officer — Chairman & CEO · Director
Period of report
Sep 20, 2018
Accepted (ET)
Sep 24, 2018 · 8:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001730430
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share OptionF1 | $30.93 | Sep 20, 2018 | A | 125,000 | A | — | Sep 19, 2028 | Class A Common Shares | 125,000 | 125,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three-year period thereafter. The vesting commencement date is September 20, 2018.